Last reviewed · How we verify
NCT04801030
COVID-19 Vaccine Hesitancy Among African Americans
NA trial testing YourCoViDVaxFacts in Covid19 in 300 participants. Status unknown.
30 September 2022
Quick facts
| Lead sponsor | Meharry Medical College |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 300 |
| Start date | 20 May 2021 |
| Primary completion | 30 September 2022 |
| Estimated completion | 30 September 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- YourCoViDVaxFacts
Conditions studied
- Covid19 — all drugs for Covid19 →
- Vaccine Refusal — all drugs for Vaccine Refusal →
- Communication — all drugs for Communication →
Sponsor
Meharry Medical College
Who can join
18 and older, any sex, with Covid19 or Vaccine Refusal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Coronavirus disease 2019 (COVID-19) has created a "state of emergency" for African Americans in the US. Recent findings indicate 31% of adults self-reported "wait and see" of the COVID-19 vaccine, of which 16% were African American. This project seeks to test the feasibility and impact of a multi-layered, culturally-appropriate social marketing intervention targeting COVID-19 vaccine hesitant (VH) African Americans to increase vaccine confidence, uptake, and completion of multi-dose vaccine series in Nashville/Davidson County, Tennessee. This study's novelty lies in being the first to assess feasibility and preliminary efficacy of a multi-layered, culturally-appropriate social marketing intervention to promote COVID-19 vaccination among African Americans in TN. Clinical significance is increased vaccine uptake and decreased COVID-19 burden and disparities.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Interventions to increase COVID-19 vaccine uptake: a scoping review.
Andreas M, Iannizzi C, Bohndorf E, Monsef I, et al · · 2022 · cited 24× · PMID 35920693 · DOI 10.1002/14651858.cd015270
Verify or expand the search:
- PubMed search for NCT04801030
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid19
Currently open trials in the same condition.
- NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
- NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
- NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
- NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting
Other Meharry Medical College trials
Trials by the same sponsor.
- NCT07201948 — Team Lifestyle Immersion Hypertension Control Project · NA · recruiting
- NCT07137026 — Trauma-informed Care for Youth With HIV in Memphis · NA · active not recruiting
- NCT05663671 — Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD · unknown
- NCT05844020 — Perceptions of Trauma and Violence Informed Care · NA · recruiting
- NCT04971889 — Diabetes Medical Nutrition Therapy in Southeastern African American Women · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04801030 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Meharry Medical College
- Last refreshed: 18 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04801030.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing